![]() |
|
|
Vol. 288, Issue 2, 535-543, February 1999
Department of Psychology, Rutgers University, Piscataway, New
Jersey (C.E.L., F.M., J.L.F.); and
Center for Bioengineering,
University of Washington, Seattle, Washington (D.M.F.)
We investigated dose-response cocaine pharmacokinetic and metabolite
profiles in a within-subject design after intravenous bolus cocaine
administration (1-4 mg/kg) in rats under a food-limited regimen.
Cocaine was rapidly distributed (T1/2
= 1.09 min) and eliminated (T1/2
= 14.93 min). Norcocaine was not detected. The free fraction of cocaine was
31.3-33.1% for serum cocaine concentrations of 0.5 to 1 µg/ml.
Parallel pharmacodynamics was studied using performance on a
contingency-controlled timing behavior, a differential reinforcement of
low rate schedule (45 s) in 3-h sessions. Cocaine increased the
shorter-response rate and decreased the density of reinforcement in a
dose- and time-related fashion. The increased shorter-response rate is
the stimulatory effect herein reported. The changes in shorter-response
rate and the density of reinforcement were directly interpretable as
functions of cocaine concentrations in the respective hypothetical
effect compartments by using sigmoidal Emax
and inhibitory Emax models, respectively.
Because the concentration at half of Emax
for the shorter-response rate (EC50 = 0.467 µg/ml) was
greater than that for density of reinforcement (IC50 = 0.070 µg/ml), the former began to return toward baseline sooner than
the latter. Only as cocaine concentration decreased to values smaller
than the EC50 did the density of reinforcement begin to
return toward baseline. Thus, the density of reinforcement is an index
for evaluating the deficit in timing performance. The
concentration-effect plot confirmed that the intensity of the effects
of cocaine depends solely on concentration regardless of the dose.
These results demonstrated that the pharmacokinetic-pharmacodynamic
analysis allows the identification of the stimulant action of cocaine, which in turn delineates its consequence on timing performance.
This article has been cited by other articles:
![]() |
H. Sun, M. L. Shen, Y.-P. Pang, O. Lockridge, and S. Brimijoin Cocaine Metabolism Accelerated by a Re-Engineered Human Butyrylcholinesterase J. Pharmacol. Exp. Ther., August 1, 2002; 302(2): 710 - 716. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Lau and L. Sun The Pharmacokinetic Determinants of the Frequency and Pattern of Intravenous Cocaine Self-administration in Rats by Pharmacokinetic Modeling Drug Metab. Dispos., March 1, 2002; 30(3): 254 - 261. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Sun and C. E. Lau Simultaneous Pharmacokinetic Modeling of Cocaine and Its Metabolites, Norcocaine and Benzoylecgonine, after Intravenous and Oral Administration in Rats Drug Metab. Dispos., September 1, 2001; 29(9): 1183 - 1189. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Lau, L. Sun, Q. Wang, A. Simpao, and J. L. Falk Oral Cocaine Pharmacokinetics and Pharmacodynamics in a Cumulative-Dose Regimen: Pharmacokinetic-Pharmacodynamic Modeling of Concurrent Operant and Spontaneous Behavior within an Operant Context J. Pharmacol. Exp. Ther., November 1, 2000; 295(2): 634 - 643. [Abstract] [Full Text] |
||||